Global Bioenergies announces break-through in direct biological production of butadiene
Global Bioenergies announced having succeeded in the production of bio-sourced butadiene by direct fermentation. It is the first time ever an entirely biological production process – i.e. without any chemical step - is reported for butadiene.
Butadiene is a key platform molecule of the petrochemical industry with a world-wide market of over 10 million metric tons per year. As of today, butadiene is exclusively obtained from fossil resources, principally through extraction from naphtha cracking. Given the decrease in naphtha cracking capacities, there is a need for alternative routes to butadiene. In this context Global Bioenergies has signed in 2011 a collaboration agreement with Synthos to develop a direct fermentation route allowing a cost-effective transformation of renewable resources into butadiene. Since such a direct biological route does not exist in nature, Global Bioenergies first had to invent a new metabolic pathway comprised of a series of non-natural enzymatic reactions. This step was successfully achieved in December 2012.
The next step consisted in improving the activity of those enzymes and implementing them into a bacterial strain.
Most read news
Other news from the department research and development

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
DSM receives grant of US Department of Energy for biotechnology research
Norwood_(charity)

Schizophrenia manifests itself in the brain structure - The symptoms of schizophrenia vary greatly from person to person

ImageBiopsy Lab - Wien, Austria
Eppendorf grows faster than the market
La Jolla Institute finds previous seasonal flu infections may provide some level of H1N1 immunity

Sequential antibiotic therapy in the laboratory and in patients - Rapid switching between different antibiotics could prevent the evolution of resistance and lead to successful treatment of patients

dimes AUTOMATION GmbH - Bonn, Germany
Q Chip appoints Tim Sparey as Chief Executive Officer - Completes £2.0 Million Funding Round

Suffocating cancer cells - Self-assembling molecules could help in cancer therapy

HM-Software - Adelheidsdorf, Germany
